A recent study conducted in Japan showed significant early post-administration improvements in sepsis patients who were given a single-dose administration of intravenous immune globulin (IVIG).
U.S. Health and Human Services announced $150 million in awards will be issued under the Affordable Care Act to support new full-time healthcenter delivery sites across the nation.
New research shows that women have a stronger immune response than men when given the flu vaccine, which may mean vaccinated women are better protected against catching the flu than vaccinated men.
Updates on recent FDA approvals, appointments, acquisitions and alliances in the pharmaceutical industry.
The U.S. Department ofHealth and Human Services announced $55.5 million in grants to support training for health professionals and bolster the size of the nation’s healthcare workforce.
Updates on clinical trials for vaccines against a protein believed to cause Alzheimer's, clostridium difficile and RSV.
Researchers at King’s College London have identified a new gene, PIM1, which could be an effective target for innovative treatments and therapies for psoriasis, an autoimmune disease.
A new study conducted by the Centers for Disease Control and Prevention shows that the number of childhood vaccines administered, either in a single day or during the first two years of life, has no bearing on autism risk.
A Canadian study showed that pregnant women who are vaccinated against the flu are significantly less likely to deliver premature or low-birth-weight babies compared with unvaccinated expectant mothers.
DiaVacs’ type 1 diabetes therapy DV-0100 has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA).
A new international study has found that vaccines may prevent the risk of strokes in children.
Insurers that want to sell plans through the federal exchanges for 2015 would have to do more to ensure members have access to an adequate network of providers.